UnitedHealth Group is grappling with its first projected annual revenue decline since 1989, prompting analysts from Piper Sandler and Morgan Stanley to adjust their price targets. The company's shares plummeted nearly 20% as concerns over Medicare rate changes and revenue forecasts weighed heavily on investor sentiment. Despite reporting $113.2 billion in revenue for the last quarter, this fell short of expectations, and adjusted operating earnings experienced a steep drop, affecting overall market confidence.
“Piper Sandler analyst Jessica Tassan · remains bullish on · UnitedHealth (UNH) stock · true”
“Piper Sandler analyst Jessica Tassan · lowered her price target on · UNH stock · $396 from $417”
“Piper Sandler analyst Jessica Tassan · keeps an · Overweight rating on UNH · true”
“NYSE:UNH · is preparing for · first projected annual revenue decline · since 1989”
“UnitedHealth Group Incorporated (NYSE:UNH) · is included among · the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds”
“Morgan Stanley analyst Erin Wright · trimmed her price target on · UnitedHealth Group Incorporated (NYSE:UNH) · $409 from $411”
“UnitedHealth Group Incorporated (NYSE:UNH) · is the parent of · the largest private health insurer in the US”
“UnitedHealth Group Inc. · volume · stock · 8,476,227”
“Berkshire Hathaway · purchased · 5,039,564 UNH shares · in the second quarter”
“Berkshire Hathaway · bought UNH stock at a price between · $248.88 and $606.36 per share”
“UnitedHealth · reported earnings per share of · $2.11”
“UnitedHealth · reported revenue of · $113.22 billion”
